Abstract
Early diagnosis of peritoneal spread in malignant disease
is essential to prevent unnecessary laparotomies and to
select the patients in whom complete cytoreduction is
feasible. Although anatomic imaging is the mainstay for
evaluating peritoneal seeding, small neoplastic implants
can be difficult to detect with CT andMR imaging. FDG
PET-CT has the potential to improve detection of peritoneal
metastases as lesion conspicuity is high at PET
due to low background activity and fused PET-CT offers
the combined benefits of anatomic and functional
imaging. Correlation of uptake modalities with the
pathogenesis of intraperitoneal spread of malignancies,
provides a rational system of analysis and is essential to
define disease. Distinct patterns appear to predict the
presence of either nodular or diffuse peritoneal pathology.
Main pitfalls are related to normal physiologic
activity in bowel loops and blood vessels or focal retained
activity in ureters and urinary bladder. PET-CT is
most suitable in patients with high tumor markers and
negative or uncertain conventional imaging data and in
selecting patients for complete cytoreduction. FDG PETCT
adds to conventional imaging in the detection and
staging of peritoneal carcinomatosis and is a useful
diagnostic tool in monitoring response to therapy and in
long term follow-up.
Lingua originale | English |
---|---|
pagine (da-a) | 391-402 |
Numero di pagine | 12 |
Rivista | Abdominal Imaging |
Stato di pubblicazione | Pubblicato - 2009 |
Keywords
- 18F-FDG
- PET-CT
- carcinomatosis